A bias for long ideas over short ones helped improve the ROI the bottom fishing for value strategy. Two areas that benefit the most from markets recovering include energy and biotech sectors. The newest long idea is a surprising one: Valeant Pharmaceuticals (VRX). The company restored some confidence from shareholders after it said it did not expect any more restatement of earnings. It also expects to file its 10K by the end of this month. Beyond this month, VRX’s outlook is uncertain. This means VRX should be looked at as a short-term trade only.
Higher confidence from investors that Kinder Morgan (KMI) has its debt levels and spending in check gave the pick a 10% ROI since April 4. Energy prices are still fluctuating, but Kinder is one way to gain exposure here.
In the tech space, RackSpace (RAX) continued its bounce from the bottom. The ROI is 40.8%. Similarly, Fitbit (FIT), Zynga (ZNGA), and Intel (INTC) all have positive ROIs of 31.5%, 17.2%, and 24.9% respectively. Conversely, Ubiquiti (UBNT)’s sell idea is down 9.4%.
The Micro-cap value stock ideas strategy is slowly recovering. Short-selling Vivint Solar (VSLR) and SunEdison (SUNE) helped offset the ROI lost from the Trina Solar (TSL) buy idea.
